FDMT
4D Molecular Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.22
+2.28%0
Insider buys (3m)
9
Insider sells (3m)
-$2.7M
Net value (3m)
+14.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 20, 2026 | Bizily Scott · officer: Chief Legal Officer | Sale | 1,635 | $13 |
| Oct 20, 2026 | Bizily Scott · officer: Chief Legal Officer | M-Exempt | 1,635 | $4.14 |
| Oct 7, 2026 | Kirn David · director, officer: See Remarks | Sale | 58,061 | $13 |
| Oct 7, 2026 | Kirn David · director, officer: See Remarks | Sale | 272 | $14 |
| Sep 22, 2026 | Bizily Scott · officer: Chief Legal Officer | Sale | 1,635 | $14 |
| Sep 22, 2026 | Bizily Scott · officer: Chief Legal Officer | M-Exempt | 1,635 | $4.14 |
| Sep 16, 2026 | Kirn David · director, officer: See Remarks | Sale | 58,333 | $14 |
| Sep 3, 2026 | Bizily Scott · officer: Chief Legal Officer | Sale | 584 | $14 |
| Sep 3, 2026 | Bizily Scott · officer: Chief Legal Officer | M-Exempt | 584 | $6.49 |
| Aug 21, 2026 | Kirn David · director, officer: See Remarks | Sale | 25,927 | $16 |
| Aug 21, 2026 | Kirn David · director, officer: See Remarks | Sale | 43,149 | $15 |
| Aug 21, 2026 | Kirn David · director, officer: See Remarks | M-Exempt | 50,000 | $4.14 |
| Aug 17, 2026 | Bizily Scott · officer: Chief Legal Officer | M-Exempt | 1,635 | $4.14 |
| Aug 17, 2026 | Bizily Scott · officer: Chief Legal Officer | Sale | 1,635 | $12 |
| Aug 5, 2026 | Kirn David · director, officer: See Remarks | Sale | 26,842 | $10 |
| Aug 4, 2026 | Kirn David · director, officer: See Remarks | Sale | 12,415 | $10 |
| Jul 14, 2026 | Kirn David · director, officer: See Remarks | Sale | 15,283 | $12 |
| Jul 14, 2026 | Kirn David · director, officer: See Remarks | Sale | 42,608 | $13 |
| Jul 14, 2026 | Kirn David · director, officer: See Remarks | Sale | 442 | $13 |
| Jul 2, 2026 | Bizily Scott · officer: Chief Legal Officer | M-Exempt | 5,752 | $6.49 |
| Jul 2, 2026 | Bizily Scott · officer: Chief Legal Officer | M-Exempt | 814 | $4.14 |
| Jul 2, 2026 | Bizily Scott · officer: Chief Legal Officer | Sale | 6,566 | $14 |
| Jun 25, 2026 | Bizily Scott · officer: Chief Legal Officer | M-Exempt | 9,810 | $4.14 |
| Jun 25, 2026 | Bizily Scott · officer: Chief Legal Officer | Sale | 9,810 | $12 |
| Jun 23, 2026 | Kirn David · director, officer: See Remarks | Sale | 114,746 | $10 |
| Jun 18, 2026 | Miller-Rich Nancy · director | A-Award | 50,000 | $9.42 |
| Jun 18, 2026 | Chacko Jacob · director | A-Award | 50,000 | $9.42 |
| Jun 18, 2026 | SBLENDORIO GLENN · director | A-Award | 50,000 | $9.42 |
| Jun 18, 2026 | MILLIGAN JOHN F · director | A-Award | 75,000 | $9.42 |
| Jun 18, 2026 | GRAY SUSANNAH · director | A-Award | 50,000 | $9.42 |
Institutional positioning
13F filings over the trailing two quarters
New 61Increased 105Reduced 82Sold out 21
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Jupiter Topco LLC | New Position | 5,746,289 | Aug 14, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 5,247,151 | May 18, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 5,049,779 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Reduced | 5,049,779 | May 15, 2026 |
| BlackRock, Inc. | Increased | 4,546,059 | Aug 7, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 4,258,668 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 4,205,438 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 4,145,303 | May 13, 2026 |
| NOVO HOLDINGS A/S | Unchanged | 3,650,737 | May 15, 2026 |
| Novo Holdings A/S | Reduced | 3,249,178 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 2,911,109 | Sep 22, 2026 |
| BVF INC/IL | Reduced | 2,879,289 | May 15, 2026 |
| BVF INC/IL | Unchanged | 2,879,289 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 2,707,875 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | New Position | 2,511,887 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 20, 2026